Rare diseases
Investigational molecules
Locations
Back to Slovakia7 clinical trials in Nova Dubnica, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
SlovakiaStudy on the Long-Term Safety of Brivaracetam for Children and Young Adults with Childhood or Juvenile Absence Epilepsy
SlovakiaStudy on AVP-786 for Treating Agitation in Alzheimer's Dementia Patients
SlovakiaStudy on the Long-term Safety of Cenobamate for Patients with Primary Generalized Tonic-Clonic Seizures
SlovakiaStudy of brivaracetam as a treatment for childhood and juvenile absence epilepsy in patients aged 2-25 years
SlovakiaStudy on the Effectiveness and Safety of Cenobamate for Patients Aged 12 and Older with Primary Generalized Tonic-Clonic Seizures
SlovakiaStudy of XPro1595 for Patients with Early Alzheimer's Disease and Inflammation Markers
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on Alzheimer's Disease treatments, including studies evaluating new therapies for early-stage patients with inflammatory biomarkers and investigating treatments for agitation in dementia patients.
These trials aim to improve cognitive performance and quality of life for patients with neurodegenerative conditions.
Comprehensive research into various forms of epilepsy, with particular focus on developing treatments for primary generalized tonic-clonic seizures and absence epilepsy in younger patients.
Clinical investigations are evaluating both short-term efficacy and long-term safety of anticonvulsant therapies.
Innovative research exploring preventative treatments for migraine patients who have not responded to conventional therapies, testing new approaches to chronic pain management.
These studies focus on developing alternative solutions for patients with difficult-to-treat neurological pain conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
